Application 084779
- Type
- ANDA
- Sponsor
- WATSON LABS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ORPHENADRINE CITRATE | ORPHENADRINE CITRATE | INJECTABLE;INJECTION | 30MG/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0591-3222 | Orphenadrine Citrate | Orphenadrine Citrate | Actavis Pharma, Inc. | ANDA | Current |